摘要:
The present invention provides a pharmaceutical composition containing the following compound having antiviral action:
P is hydrogen or a group to form a prodrug; A 1 is CR 1 A R 1 B , S or O; A 2 is CR 2 A R 2 B , S or O; A 3 is CR 3 A R 3 B , S or O; A 4 is each independently CR 4 A R 4 B , S or O; the number of hetero atoms among atoms constituting the ring which consists of A 1 , A 2 , A 3 , A 4 , nitrogen atom adjacent to A 1 and carbon atom adjacent to A 4 , is 1 or 2; R 1 A and R 1 B are each independently hydrogen, halogen, alkyl, or the like; R 2 A and R 2 B are each independently hydrogen, halogen, alkyl, or the like; R 3 A and R 3 B are each independently hydrogen, halogen, alkyl, or the like; R 4 A and R 4 B are each independently hydrogen, halogen, alkyl, or the like; R 3 A and R 3 B may be taken together with an adjacent carbon atom to form non-aromatic carbocycle or non-aromatic heterocycle; R 1 is fluorine; m is any integer of 1 to 2; and n is any integer of 1 to 2.
摘要:
The present invention provides a pyrone derivative and a pyridone derivative, which are novel intermediates for synthesizing an anti-influenza drug, a method of producing the same, and a method of using the same.
摘要:
This invention provides compounds having antiviral activities especially inhibiting activity for influenza virus, more preferably provides substituted 3-hydroxy-4-pyridone derivatives having cap-dependent endonuclease inhibitory activity.
摘要:
This invention provides compounds having antiviral activities especially inhibiting activity for influenza virus, more preferably provides substituted 3-hydroxy-4-pyridone derivatives having cap-dependent endonuclease inhibitory activity.
摘要:
The present invention provides a novel compound having an antiviral activity, in particular, an HIV replication inhibiting activity, as well as a pharmaceutical composition, in particular, an anti-HIV agent.
wherein ring A is substituted or unsubstituted carbocycle or substituted or unsubstituted heterocycle; R 1 is substituted or unsubstituted alkyl etc.; R 2 is substituted or unsubstituted alkyloxy etc.; n is 1 or 2; R 3 is substituted or unsubstituted carbocyclyl or substituted or unsubstituted heterocyclyl; R 4 is a hydrogen atom etc.; R 6 is substituted or unsubstituted alkyl etc.
摘要:
This invention provides compounds having antiviral activities especially inhibiting activity for influenza virus, more preferably provides substituted 3-hydroxy-4-pyridone derivatives having cap-dependent endonuclease inhibitory activity.
摘要:
The present invention provides a compound represented by formula (I) :
wherein the dashed line indicates the presence or absence of a bond; R 1 is carboxy or the like; L is substituted or unsubstituted non-aromatic carbocyclyldiyl or the like; R 2 is substituted or unsubstituted alkyl; R 3 is a hydrogen atom or the like; X is =CR X -or =N-; Y is =CR Y - or =N-; U is -CR U = or -N=; V is -CR V = or -N=; W is =CR W - or =N-; Z A is -C= or -N-; Z B is -CR 5 R 6 - or the like; Z C is -CR 7 R 8 - or the like; R X , R Y , R V and R W are each independently a hydrogen atom or the like; R U is a hydrogen atom or the like; R 5 and R 6 are each independently a hydrogen atom or the like; R 7 and R 8 are each independently a hydrogen atom or the like; R 4 is substituted or unsubstituted alkyloxy or the like, or a pharmaceutically acceptable salt thereof, having an antiviral activity; and a pharmaceutical composition comprising the same.
摘要:
The present invention provides a compound represented by formula (I) :
wherein the dashed line indicates the presence or absence of a bond; R 1 is carboxy or the like; L is substituted or unsubstituted non-aromatic carbocyclyldiyl or the like; R 2 is substituted or unsubstituted alkyl; R 3 is a hydrogen atom or the like; X is =CR X -or =N-; Y is =CR Y - or =N-; U is -CR U = or -N=; V is -CR V = or -N=; W is =CR W - or =N-; Z A is -C= or -N-; Z B is -CR 5 R 6 - or the like; Z C is -CR 7 R 8 - or the like; R X , R Y , R V and R W are each independently a hydrogen atom or the like; R U is a hydrogen atom or the like; R 5 and R 6 are each independently a hydrogen atom or the like; R 7 and R 8 are each independently a hydrogen atom or the like; R 4 is substituted or unsubstituted alkyloxy or the like, or a pharmaceutically acceptable salt thereof, having an antiviral activity; and a pharmaceutical composition comprising the same.
摘要:
The present invention provides a compound having antiviral effects, particularly having growth inhibitory activity on influenza viruses, a preferred example of the compound being a substituted 3 - hydroxy-4-pyridone derivative prodrug having cap-dependent endonuclease inhibitory activity.